
Loading, please wait...

Loading, please wait...

Hepatocellular carcinoma (HCC) remains a significant clinical challenge in India due to late-stage diagnosis and metabolic flexibility. Recent findings demonstrate that TRIB3 HCC metabolic adaptation serves as a critical survival mechanism when glutamine levels are low. Researchers discovered that TRIB3, a pseudokinase, acts as a nuclear safeguard for DNA repair fidelity during nutrient stress.
Furthermore, the study explains that glutamine deprivation triggers c-Jun-dependent upregulation of TRIB3. This protein subsequently binds to G-quadruplex DNA (G4-DNA) structures across the genome. Specifically, TRIB3 recruits the helicase DDX5 to resolve these complex structures. Consequently, this cooperative functional complex maintains the transcription of essential homologous recombination genes like BRCA1 and RAD51AP1.
Without the TRIB3-DDX5 complex, HCC cells suffer from exaggerated G4-DNA accumulation. This leads to replication catastrophe and heightened DNA damage. Therefore, researchers suggest that TRIB3 levels correlate directly with poor clinical outcomes. Additionally, in vivo experiments showed that silencing TRIB3 suppresses xenograft growth, particularly when combined with glutamine-deficient diets. Thus, targeting the TRIB3-DDX5-G4 axis offers a promising therapeutic strategy for TRIB3-high malignancies.
TRIB3 facilitates metabolic adaptation by recruiting DDX5 to resolve G-quadruplex DNA structures. This action ensures that DNA repair genes remain active, preventing genomic instability and replication catastrophe.
Depleting TRIB3 causes G-quadruplexes to accumulate, which blocks the transcription of repair genes like BRCA1. This leads to increased DNA damage and eventually triggers apoptosis in the cancer cells.
While targeting glutamine alone often fails due to resistance, combining it with TRIB3 inhibition may overcome this adaptive survival mechanism, making tumors more vulnerable to therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies the TRIB3-DDX5 axis as a vital mechanism for hepatocellular carcinoma survival by resolving G-quadruplexes during glutamine deprivat...
6 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today